Coherus BioSciences Announces New Employment Inducement Grants

REDWOOD CITY, Calif., Feb. 23, 2024 (GLOBE NEWSWIRE) — Coherus BioSciences, Inc. (“Coherus” or the “Company”, Nasdaq: CHRS), today announced that effective February 20, 2024, the compensation committee of the Company’s board of directors granted options to purchase an aggregate of 170,000 shares of the common stock of the…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks